日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A µ-opioid receptor superagonist analgesic with minimal adverse effects

一种μ-阿片受体超激动剂镇痛药,不良反应极小

Gomez, Juan L; Ventriglia, Emilya N; Frangos, Zachary J; Sulima, Agnieszka; Robertson, Michael J; Sacco, Michael D; Budinich, Reece C; Giosan, Ilinca M; Xie, Tongzhen; Solis, Oscar; Tischer, Anna E; Bossert, Jennifer M; Caldwell, Kiera E; Bonbrest, Hannah; Essmann, Amelie; Garçon-Poca, Zelai M; Choi, Shinbe; Noya, Michael R; Limiac, Feonil; Arce, Ali; Glatfelter, Grant C; Robinson, Margaret; Chen, Li; Mullarkey, Angelina A; Brademan, Dain R; Enten, Garrett; Dunne, William; Quiroz, César; Schoenborn, Ingrid; Lee, Chae Bin; Rais, Rana; Holt, Daniel P; Dannals, Robert F; Shi, Lei; Hüttenhain, Ruth; Ferré, Sergi; Kiyatkin, Eugene; Bonaventura, Jordi; Shaham, Yavin; Zachariou, Venetia; Baumann, Michael H; Skiniotis, Georgios; Rice, Kenner C; Michaelides, Michael

A reversible allosteric inhibitor of GlyT2 for neuropathic pain without on-target side effects

一种可逆的GlyT2变构抑制剂,用于治疗神经性疼痛,且无靶向副作用。

Cantwell Chater, Ryan P; Peiser-Oliver, Julian; Pati, Tanmay K; Quinn, Ada S; Lotsaris, Irina; Frangos, Zachary J; Anderson, Kristen E; Tischer, Anna E; Williams-Noonan, Billy J; Aubrey, Karin R; O'Mara, Megan L; Michaelides, Michael; Mohammadi, Sarasa A; Cioffi, Christopher L; Vandenberg, Robert J; Shahsavar, Azadeh

An emerging role for synaptic Zn(2+) in substance use disorders

突触锌离子(Zn(2+))在物质使用障碍中的新兴作用

Solis, Oscar; Curry, Fallon P; Frangos, Zachary J; Dunne, William; Schoenborn, Ingrid; Lauer, Alyssa; Gomez, Juan L; Ventriglia, Emilya N; Bonaventura, Jordi; Michaelides, Michael

The role of central versus peripheral opioid receptors in fentanyl-induced brain hypoxia

芬太尼诱导脑缺氧中枢与外周阿片受体的作用

Kiyatkin, Eugene A; Limiac, Feonil G; Noya, Michael R; Gomez, Juan L; Michaelides, Michael; Shaham, Yavin

D2 autoreceptors gate vulnerability to cocaine use disorder

D2自身受体控制对可卡因使用障碍的易感性

Murray, Erin M; Diaz-Urbina, Daniel; Bock, Roland; Ventriglia, Emilya; Tischer, Anna; Shin, Jung Hoon; Lee, Seul Ah; Anderson, Lucy G; Cerveny, Sydney; Bleimeister, Isabel; Bocarsly, Miriam E; Michaelides, Michael; Alvarez, Veronica A

Cocaine chemogenetics blunts drug-seeking by synthetic physiology.

可卡因化学遗传学通过合成生理学抑制药物渴求。

Gomez Juan L, Magnus Christopher J, Bonaventura Jordi, Solis Oscar, Curry Fallon P, Levinstein Marjorie R, Budinich Reece C, Carlton Meghan L, Ventriglia Emilya N, Lam Sherry, Wang Le, Schoenborn Ingrid, Dunne William, Michaelides Michael, Sternson Scott M

Redefining Ketamine Pharmacology for Antidepressant Action: Synergistic NMDA and Opioid Receptor Interactions?

重新定义氯胺酮的抗抑郁药理学:NMDA受体和阿片受体的协同作用?

Levinstein, Marjorie R; Budinich, Reece C; Bonaventura, Jordi; Schatzberg, Alan F; Zarate, Carlos A Jr; Michaelides, Michael

Locomotor activity depends on β-arrestin recruitment by the dopamine D(1) receptor in the striatal D(1)-D(3) receptor heteromer

运动活性依赖于纹状体D(1)-D(3)受体异聚体中多巴胺D(1)受体募集β-arrestin。

Evans, Alexandra H; Ciruela-Jardí, Marc; Rea, William; Keegan, Bradley M; Levinstein, Marjorie R; Bonifazi, Alessandro; Cao, Jianjing; Jackson, Shelley N; Shi, Lei; Casajuana-Martin, Nil; Cai, Ning-Sheng; Casadó, Vicent; Earley, Christopher J; Newman, Amy H; Michaelides, Michael; Pardo, Leonardo; Moreno, Estefanía; Ferré, Sergi

The dopaminergic effects of esketamine are mediated by a dual mechanism involving glutamate and opioid receptors

艾司氯胺酮的多巴胺能效应是通过涉及谷氨酸受体和阿片受体的双重机制介导的。

Rizzo, Arianna; Garçon-Poca, Maria Zelai; Essmann, Amelie; Souza, Adriana Jesus; Michaelides, Michael; Ciruela, Francisco; Bonaventura, Jordi

Bifunctional Modulation of NMDA and Opioid Receptors in Ketamine Reinforcement and Misuse: Implications for Substance Use Disorder Treatment

氯胺酮强化和滥用中NMDA受体和阿片受体的双功能调节:对物质使用障碍治疗的启示

Levinstein, Marjorie R; Schoenborn, Ingrid; Manza, Peter; Schatzberg, Alan F; Zarate, Carlos A Jr; Jordi Bonaventura; Michaelides, Michael